MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0127184
Vitaris Pharmaceutical Private Limited
Vitaris Pharmaceutical Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹43 Lakh
▲ 38% YoY
Net profit · FY 2025
₹34,049
Net margin 0.8%
EBITDA · FY 2025
₹51,119
EBITDA margin 1.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Vitaris Pharmaceutical Private Limited
Data last updated:
Vitaris Pharmaceutical Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC305792. Its GSTIN is 27AAGCV3072J1Z2 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suraj Shivaji Chavan and Tushar Punjahari Walunj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 97 Mhada Shanurwadi, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹43 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹34,049 (net margin 0.8%) and EBITDA of ₹51,119 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 32% over five years.
Vitaris Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0127184).
Company details
CIN U74999MH2018PTC305792
Registration Number 305792
Incorporation Date 28 February 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0127184
Recognitions & Rankings of Vitaris Pharmaceutical
Contact details
Vitaris Pharmaceutical Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No. 97 Mhada Shanurwadi, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vitaris Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Vitaris Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vitaris Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vitaris Pharmaceutical Private Limited, buy the company report.
Financials of Vitaris Pharmaceutical Private Limited
FY 2025 filings availableVitaris Pharmaceutical Private Limited reported revenue of ₹43 Lakh (up 38% YoY) for FY 2025.
Revenue · FY 2025
₹43 Lakh ▲ 38%
Net profit · FY 2025
₹34,049 margin 0.8%
EBITDA · FY 2025
₹51,119 margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 31%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 4%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 38% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51,119 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,049 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vitaris Pharmaceutical Private Limited, buy the company report.
Board of directors of Vitaris Pharmaceutical Private Limited
Vitaris Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suraj Shivaji Chavan | Director | 28 Feb 2018 | 8 Years 8 Months | Current |
| Tushar Punjahari Walunj | Director | 28 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Vitaris Pharmaceutical Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medistream Biotech Private Limited | ₹43.12 Lakh (FY 2025) | 11.0% | Vadodara, Gujarat, India | |||
| Amare Cor Pharmaceuticals Private Limited | ₹43.06 Lakh (FY 2024) | -4.0% | Ranchi, Jharkhand, India | |||
| Swapra Pharma Private Limited | ₹43.05 Lakh (FY 2024) | 329.0% | New Delhi, Delhi, India | |||
| Hems & Nephews Exports Private Limited | ₹43 Lakh (FY 2024) | -34.0% | Chennai, Tamil Nadu, India | |||
| Vitaris Pharmaceutical Private Limitedthis company | ₹43 Lakh (FY 2025) | ₹34,049 | 0.8% | 38.0% | Aurangabad, Maharashtra, India | |
| Arlics Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2025) | 1.0% | Mehsana, Gujarat, India | |||
| Straumann Dental India Private Limited | ₹42.92 Lakh (FY 2016) | 62.0% | Gurgaon, Haryana, India | |||
| Kiraat Pharmaceutical Private Limited | ₹42.89 Lakh (FY 2025) | 536.0% | Noida, Uttar Pradesh, India | |||
| Arnacon Wellness Private Limited | ₹42.76 Lakh (FY 2024) | -56.0% | Guwahati, Assam, India | |||
| Ransar Health Care Private Limited | ₹42.74 Lakh (FY 2024) | 12.0% | Patna, Bihar, India |
To see the full peer comparison of Vitaris Pharmaceutical Private Limited, buy the company report.
Auditor
Vitaris Pharmaceutical Private Limited is audited by Ratan Chandak & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ratan Chandak & Co. | FY 2023 | 108696W |
Shareholding
The shareholding of Vitaris Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vitaris Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vitaris Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vitaris Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vitaris Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCV3072J1Z2 | Maharashtra | Active | 30 Jun 2018 |
To see the full GST registrations and return filing status of Vitaris Pharmaceutical Private Limited, buy the company report.
Recent activity
Vitaris Pharmaceutical Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Suraj Shivaji Chavan was appointed as Director on 28 Feb 2018.
AGM
Vitaris Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vitaris Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Suraj Shivaji Chavan was appointed as Director.
Appointed
Tushar Punjahari Walunj was appointed as Director.
Incorporation
28 Feb 2018
Vitaris Pharmaceutical Private Limited was registered on 28 Feb 2018 with Roc Mumbai & aged 8 years 8 months as per MCA records.
Frequently asked questions
Vitaris Pharmaceutical is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 February 2018 (8+ years old) and is registered under CIN U74999MH2018PTC305792.
Vitaris Pharmaceutical has 2 current directors:
- Suraj Shivaji Chavan - Director
- Tushar Punjahari Walunj - Director
The latest financial statements of Vitaris Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Vitaris Pharmaceutical is 27AAGCV3072J1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vitaris Pharmaceutical is U74999MH2018PTC305792. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vitaris Pharmaceutical was incorporated on 28 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vitaris Pharmaceutical by revenue are Medistream Biotech Private Limited, Amare Cor Pharmaceuticals Private Limited, Swapra Pharma Private Limited, Hems & Nephews Exports Private Limited, Arlics Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Suraj Shivaji Chavan was appointed as Director on 28 Feb 2018. Tushar Punjahari Walunj was appointed as Director on 28 Feb 2018.
Yes, Vitaris Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0127184).
The registered office of Vitaris Pharmaceutical is at H No. 97 Mhada Shanurwadi, Aurangabad, Maharashtra, India – 431001.
Vitaris Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages